Cure My Disease

Don't miss your cure!

 Log in / Sign up

Coffee chat classroom: new teaching method boosts nursing Students' drug knowledge

NCT ID NCT07601984

Knowledge-focused Sponsor: Ying Guo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a teaching method called World Café, where students learn pharmacology through structured group discussions, similar to a coffee shop conversation. About 890 nursing students took part to see if this approach improved their exam scores and self-directed learning. The goal was to find a more engaging way to teach future nurses about medications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

890 people

The number who actually took part.

Started

Mar 2023

Finished

Jul 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 23 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Third-year undergraduate nursing students at Kunming Medical University * Enrolled in the pharmacology course during the study semester (March-July 2023 or March-July 2024) * Willing to participate and provided informed consent Exclusion Criteria: * Students who did not complete the pharmacology course or did not take the final examination * Students who did not provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Nursing education research are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Nursing education research

Contacts and locations

Locations

  • Kunming Medical University

    Kunming, Yunnan, 650500, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.